Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy.

HIV reservoir HIV-1 dendritic cells innate immunity interferon

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 04 07 2023
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Human immunodeficiency virus type 1 (HIV-1) disease manifestations differ between cisgender women and men, including better control of viral replication during primary infection and less frequent residual HIV-1 replication on antiretroviral therapy (ART) in cisgender women with HIV-1 (WWH). Investigating plasmacytoid dendritic cell (pDC) functions and HIV-1 reservoir sizes in 20 WWH on stable ART, we observed inverse correlations between interferon-α and tumor necrosis factor responses of pDCs to Toll-like receptor 7/8 stimulation and intact/total proviral HIV-1 DNA levels. Additionally, ISG15 mRNA levels in peripheral blood mononuclear cells correlated with cytokine responses of pDCs. These findings demonstrate an association between higher type I interferon responses and lower HIV-1 reservoir sizes in WWH on ART, warranting studies to identify the underlying mechanisms.

Identifiants

pubmed: 38385222
pii: 7612378
doi: 10.1093/infdis/jiae013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
Organisme : German Center for Infection Research

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. S. H. H. is an employee at AdaptVac since August 2021, a company commercializing virus-like particle display technology and vaccines. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Rebecca-Jo Thiele (RJ)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Benjamin Grünhagel (B)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Maximilian Muenchhoff (M)

Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich.
German Centre for Infection Research, Hamburg and Munich.

Maria Pujantell-Graell (M)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Linda Jocham (L)

Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich.
German Centre for Infection Research, Hamburg and Munich.

Arne Düsedau (A)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Jana Hennesen (J)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Heike Hildebrandt (H)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Sven Hendrik Hagen (SH)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Deborah Sandfort (D)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.

Madeleine J Bunders (MJ)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.
Center for Internal Medicine, III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg.

Oliver T Keppler (OT)

Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich.
German Centre for Infection Research, Hamburg and Munich.

Christian Hoffmann (C)

ICH Study Center, Hamburg, Germany.

Marcus Altfeld (M)

Department of Virus Immunology, Leibniz Institute of Virology, Hamburg.
German Centre for Infection Research, Hamburg and Munich.

Classifications MeSH